May 29, 2026
ATS Corp. (ATS) gave back 14% on its Q4 results, which missed on EPS and came with guidance for negative Y/Y growth in Q1 at the midpoint…
… driven by normalization in the life sciences segment after a strong year and an exit from some low margin transportation work. While management still expects modest Y/Y growth in fiscal 2027…
… investors will likely wait for proof, with the current multiple sitting above the long-term average.
About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.
